Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT06466720
Eligibility Criteria:
Inclusion criteria Prospective Cohort
Patients will be eligible for inclusion only if ALL of the following criteria apply:
* Age: above 18 years, no upper limit
* Diagnosis of brain metastases or meningioma, where the treatment is going to be stereotactic radiosurgery
* Karnofsky Performance Status (KPS) ≥70
* Established diagnosis of cancer with absent or controllable primary disease
* Tumour volume of less than 20cc
* Life expectancy of more than 6 months
* Able to give informed consent
Exclusion criteria Prospective Cohort
* Previous RT to the brain, including SRS
* Previous surgery to the brain
* Not willing or not able to give informed consent
Inclusion criteria Retrospective Cohort
Patients will be eligible for inclusion only if ALL of the following criteria apply:
* Age: above 18 years, no upper limit
* Diagnosis of meningioma
* Previous SRS treatment at least 1 year prior to inclusion in the study
* Most recent MRI scan (within 1 year) shows stable appearances
* Able to give informed consent
Exclusion criteria Retrospective Cohort
* Previous RT to the brain, excluding SRS
* Previous surgery to the brain
* Not willing or not able to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06466720
Study Brief:
Protocol Section:
NCT06466720